| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |